Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
11/05/2013 | US8575342 HIV inhibiting 5-heterocyclyl pyrimidines |
11/05/2013 | US8575339 Derivatives of erlotinib |
11/05/2013 | US8575338 Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers |
11/05/2013 | US8575187 Combinations of anilinopyrimidines and pyrion compounds |
11/05/2013 | US8575184 Quinazolines as potassium ion channel inhibitors |
11/05/2013 | US8575183 Heterocyclic compounds and their uses |
11/05/2013 | US8575168 Compounds and compositions as modulators of GPR119 activity |
11/05/2013 | US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
11/05/2013 | US8575153 Pyridine-3-carboxyamide derivative |
11/05/2013 | US8575143 3-aryl-substituted quinazolones, and uses thereof |
11/05/2013 | CA2609050C Method for production of 1-alkyl-3-phenyluracils |
11/05/2013 | CA2594345C Compositions and methods of treating cell proliferation disorders |
11/05/2013 | CA2593578C Cxcr4 antagonists for the treatment of medical disorders |
10/31/2013 | WO2013163190A1 Dna-pk inhibitors |
10/31/2013 | WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same |
10/31/2013 | WO2013161904A1 Sulfonamide derivative and medicinal use thereof |
10/31/2013 | WO2013161853A1 Quinazolinedione derivative |
10/31/2013 | WO2013160418A1 Novel compounds |
10/31/2013 | WO2013159286A1 Etravirine and method for preparing intermediate thereof |
10/31/2013 | WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy |
10/31/2013 | US20130289280 Novel pharmaceutical forms, and methods of making and using the same |
10/31/2013 | US20130289044 Quinazoline Compounds as Sodium Channel Blockers |
10/30/2013 | EP2657229A1 Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same |
10/30/2013 | EP2655398A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt |
10/30/2013 | EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof |
10/30/2013 | EP2655341A2 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof |
10/30/2013 | EP2655340A1 Bi-heteroaryl compounds as vps34 inhibitors |
10/30/2013 | EP2655339A1 Electronic device including a pyrimidine compound |
10/30/2013 | EP2655331A1 Glucagon receptor modulators |
10/30/2013 | CN103373971A Urea compounds serving as protein kinase inhibitors |
10/30/2013 | CN103373966A 4-anilino quinazoline amido derivatives as well as preparation methods and applications thereof |
10/30/2013 | CN103373965A Preparation methods of etravirine and intermediate body thereof |
10/30/2013 | CN103373964A Method for synthesizing 2-amido-4-p-methoxyphenyl-5-cyan-1,6-dihydropyrimidine-6-ketone |
10/30/2013 | CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
10/30/2013 | CN101668423B 2-aminopyrimidine modulators of histamine h4 receptor |
10/30/2013 | CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands |
10/29/2013 | US8569543 CCR9 inhibitors and methods of use thereof |
10/29/2013 | US8569492 Method for preparing halofuginone derivative |
10/29/2013 | US8569478 Modified 4′-nucleosides as antiviral agents |
10/29/2013 | US8569322 Lamivudine oxalate and preparation method thereof |
10/29/2013 | US8569318 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof |
10/29/2013 | US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives |
10/29/2013 | US8569310 Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use |
10/29/2013 | US8569302 Inhibitors of flaviviridae viruses |
10/29/2013 | CA2563038C Neurologically-active compounds |
10/29/2013 | CA2562965C Nucleoside derivatives and therapeutic use thereof |
10/24/2013 | WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof |
10/24/2013 | WO2013156835A1 An improved process for the preparation of erlotinib hydrochloride form a |
10/24/2013 | WO2013119916A3 Compounds for treating spinal muscular atrophy |
10/24/2013 | US20130281694 Method for preparing rosuvastatin salts |
10/24/2013 | US20130281473 Substituted isoquinolinones and quinazolinones |
10/24/2013 | US20130281448 Small molecule compounds for targeting inflammatory conditions |
10/24/2013 | US20130281429 2,4-diamino-pyrimidines as aurora inhibitors |
10/24/2013 | US20130281399 Treatment of diseases by epigenetic regulation |
10/24/2013 | US20130281398 Treatment of diseases by epigenetic regulation |
10/24/2013 | US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia |
10/23/2013 | EP2651930A1 Biarylamide inhibitors of leukotriene production |
10/23/2013 | EP2651904A1 Bispyrimidines for electronic applications |
10/23/2013 | EP2651900A1 Neprilysin inhibitors |
10/23/2013 | EP2651896A1 Neprilysin inhibitors |
10/23/2013 | CN103360369A Erlotinib, and preparation method of new intermediate of erlotinib |
10/23/2013 | CN103360342A 3-Cyanoaniline alkyl aryl piperazine derivative and application in preparing medicaments |
10/23/2013 | CN103360326A Method for refining Gefinitib crystal form I |
10/23/2013 | CN103360325A Preparation method of erlotinib hydrochloride crystal form A |
10/23/2013 | CN103360324A Novel pyrimidine derivatives and their use in perfume compositions |
10/23/2013 | CN103360305A Substituted aryl piperazine aralkyl ketone derivative and application of derivative in preparing analgesic |
10/23/2013 | CN103356636A Theramutein调节剂 Theramutein moderator |
10/23/2013 | CN102660017B High-refractivity polyarylenesulfidesulfonamide and preparation method thereof |
10/22/2013 | US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide |
10/22/2013 | US8563719 Process and intermediates for preparing lapatinib |
10/22/2013 | US8563715 Pyrimidine derivative having cell protecting effect and uses thereof |
10/22/2013 | US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists |
10/22/2013 | US8563594 S1P3 receptor inhibitors for treating pain |
10/22/2013 | US8563568 Besylate salt of a BTK inhibitor |
10/22/2013 | US8563559 Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors |
10/22/2013 | US8563558 Substituted pyridine urea compounds |
10/22/2013 | US8563557 Pyrimidine derivatives and their pharmaceutical use |
10/22/2013 | US8563539 Aminopyrimidine kinase inhibitors |
10/22/2013 | US8563512 Neprilysin inhibitors |
10/22/2013 | CA2611927C Process for the preparation of dihydroquinazolines |
10/22/2013 | CA2587545C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
10/22/2013 | CA2580150C Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
10/17/2013 | WO2013154870A1 Histone deacetylases (hdacs) inhibitors |
10/17/2013 | WO2013153162A1 Polymorph of rilpivirine hydrochloride |
10/17/2013 | WO2013153161A2 Novel polymorph of rilpivirine hydrochloride |
10/17/2013 | US20130274277 Treatment for discoid lupus |
10/17/2013 | US20130274275 4-phenylamino-quinazolin-6-yl-amides |
10/17/2013 | US20130274263 Tubulin inhibitors |
10/17/2013 | US20130274252 Quinazoline derivatives as kinase inhibitors |
10/16/2013 | EP2650286A1 Quinazoline derivatives and therapeutic use thereof |
10/16/2013 | EP2650285A1 Fungicide |
10/16/2013 | EP2650274A2 A thionation process and a thionating agent |
10/16/2013 | EP2649053A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2 |
10/16/2013 | EP2649050A1 Compounds |
10/16/2013 | CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
10/16/2013 | CN103351348A Synthetic method for 2-methylamino pyrimidine hydrochloride |
10/16/2013 | CN102304095B Preparation method of sulfadoxine |
10/16/2013 | CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents |
10/16/2013 | CN101790519B 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
10/16/2013 | CN101679307B Co-crystals of cyprodinil and pyrimethanil |